세계의 수술용 지혈제 시장 보고서(2025년)
Surgical Hemostats Global Market Report 2025
상품코드 : 1811041
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 수술용 지혈제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 CAGR 6.6%로 확대되어 50억 9,000만 달러로 성장할 것으로 예상됩니다. 이 예측 기간의 성장은 첨단 상처 봉합 제품에 대한 수요 증가, 외래수술센터(ASC) 확대, 생분해성 지혈제에 대한 선호도 증가, 지혈제 병용 사용 증가, 수술 개입이 필요한 생활 습관병의 이환율 증가에 의해 견인될 것으로 예측됩니다. 이 기간의 주요 동향으로는 흡수성 지혈제의 기술적 발전, 로봇 수술에 기술 통합, 차세대 지혈제 제제의 개발, 스마트 수술 기기 통합, 식물성 지혈제의 기술 혁신 등을 들 수 있습니다.

가까운 미래에 외상 사례 증가는 수술 지혈제 시장의 성장을 이끌 것으로 예측됩니다. 외상은 고통스러운 사건과 유해한 사건으로 인한 신체적 손상과 정신적 충격을 말하며 개인의 신체와 정신에 영향을 미칩니다. 외상 사례 증가는 주로 교통 사고의 급증으로 인한 것으로, 즉각적인 의료 치료가 필요한 중상을 일으킬 수 있습니다. 수술용 지혈제는 외상시 출혈을 빠르고 효과적으로 제어하고 출혈량을 줄여 환자를 안정시키고 추가 치료로 이어줍니다. 예를 들어, 2023년 위스콘신 주 보건 서비스국에 따르면 폭행으로 인한 외상은 2022년에 비해 3% 증가하여 1,544건에서 1,584건으로 증가했습니다. 따라서 외상 사례 증가가 수술용 지혈제 시장 확대에 박차를 가하고 있습니다.

수술용 지혈제 시장의 주요 기업은 흡수성 산화재생 셀룰로오스(ORC)와 같은 혁신적인 재료를 사용하여 첨단 제품을 개발하고 출혈 통제를 개선하고 상처 치유를 촉진하고 있습니다. 흡수성 산화재생 셀룰로오스는 수술 지혈제료에 사용되는 생분해성 식물 유래 재료로 상처 부위에 물리적 장벽을 만들어 혈전 형성을 촉진함으로써 출혈을 멈춥니다. 2022년 2월 인도의 의료기기 제조업체인 Futura Surgicare Pvt.Ltd.는 수술 중 효과적인 출혈 조절을 위해 설계된 첨단 흡수성 ORC 지혈제인 Hemostax를 발표했습니다. 본 제품은 1.5분 이내에 지혈을 시작하고 2-5분 내에 그 효과를 완료합니다. 1-2주간에 완전히 흡수되기 때문에 제거할 필요가 없습니다. Hemostax는 사용하기 쉽고 다양한 수술 부위에 적응하고, 비독성이고 생체적합성이 있으며, 약제 내성균에 대한 항균성을 가지고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Surgical hemostats are specialized tools or substances used during surgery to control bleeding by either clamping blood vessels or encouraging blood clot formation. Their purpose is to maintain a clear surgical area and minimize blood loss, improving visibility and safety throughout the procedure.

The primary types of surgical hemostats include topical thrombin-based hemostats, flowable hemostats, collagen-based hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, combination hemostats, and others. Topical thrombin-based hemostats are applied directly to bleeding areas to stimulate clotting by converting fibrinogen into fibrin through the action of thrombin. These come in various forms such as matrix and gel, sponges, sheets and pads, and powders. They are used in a wide range of surgeries including neurological, orthopedic, cardiovascular, gynecological, trauma, and plastic surgeries. These products are utilized by various end users including hospitals, ambulatory surgical centers, specialty clinics, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The surgical hemostats market research report is one of a series of new reports from The Business Research Company that provides surgical hemostats market statistics, including surgical hemostats industry global market size, regional shares, competitors with a surgical hemostats market share, detailed surgical hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the surgical hemostats industry. The surgical hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The surgical hemostats market size has grown strongly in recent years. It will grow from $3.68 billion in 2024 to $3.93 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. Growth during the historic period can be attributed to the rising number of surgical procedures, an increase in trauma and accident cases, a growing elderly population, greater adoption of minimally invasive surgical techniques, and a higher prevalence of chronic diseases.

The surgical hemostats market size is expected to see strong growth in the next few years. It will grow to $5.09 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. Growth in the forecast period is expected to be driven by increasing demand for advanced wound closure products, the expansion of ambulatory surgical centers, a growing preference for biodegradable hemostats, increased use of combination hemostatic agents, and a rising incidence of lifestyle-related diseases requiring surgical intervention. Key trends during this period include technological advancements in absorbable hemostats, integration of technology in robotic surgeries, development of next-generation hemostatic formulations, incorporation with smart surgical devices, and innovations in plant-based hemostatic products.

The increasing number of trauma cases is expected to drive the growth of the surgical hemostats market in the near future. Trauma involves physical injury or emotional shock resulting from a distressing or harmful event, affecting an individual's body or mind. The rise in trauma cases is mainly due to a surge in road traffic accidents, which cause severe injuries needing immediate medical care. Surgical hemostats assist in quickly and effectively controlling bleeding during trauma cases, reducing blood loss and stabilizing patients for further treatment. For example, in 2023, the Wisconsin Department of Health Services reported that traumatic injuries caused by assault increased by 3% compared to 2022, rising from 1,544 cases to 1,584 cases. Hence, the growing occurrence of trauma cases is fueling the expansion of the surgical hemostats market.

Leading companies in the surgical hemostats market are developing advanced products using innovative materials such as absorbable oxidized regenerated cellulose (ORC) to improve bleeding control and accelerate wound healing. Absorbable oxidized regenerated cellulose is a biodegradable, plant-derived material used in surgical hemostats to stop bleeding by creating a physical barrier and encouraging clot formation at the wound site. In February 2022, Futura Surgicare Pvt. Ltd., an India-based medical device manufacturer, introduced Hemostax, an advanced absorbable ORC hemostat designed for effective intraoperative bleeding control. This product initiates hemostasis within 1.5 minutes and completes its effect in 2 to 5 minutes. It is fully absorbed within 1 to 2 weeks, eliminating the need for removal. Hemostax is user-friendly, adapts well to various surgical sites, is non-toxic, biocompatible, and possesses antibacterial properties against drug-resistant bacteria.

In May 2025, Merit Medical Systems, Inc., a US-based medical device company, acquired Biolife Delaware for $120 million. Through this acquisition, Merit Medical Systems aims to broaden its hemostasis product portfolio and reinforce its position in the global market for rapid bleeding control solutions. BioLife Delaware, L.L.C. is a US-based medical device firm specializing in the development of surgical hemostatic products.

Major players in the surgical hemostats market are Johnson And Johnson Services Inc., Medtronic plc, Becton Dickinson And Company, Stryker Corporation, Baxter International Inc., Teleflex Corporation, Integra LifeSciences Holdings Corporation., GELITA MEDICAL GmbH, B. Braun Melsungen AG, Advanced Medical Solutions Group plc, Axio Biosolutions Pvt. Ltd., Marine Polymer Technologies Inc, Biom'up USA Inc, Lotus Surgicals Pvt. Ltd, Hemostasis LLC, Biocer Entwicklungs-GmbH, CuraMedical BV, EndoClot Plus Inc, Starch Medical Inc, Tricol Biomedical Inc.

North America was the largest region in the surgical hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in surgical hemostats report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the surgical hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The surgical hemostats market consists of sales of mechanical hemostats, active hemostats, flowable hemostats, fibrin sealants, and combination hemostats. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Surgical Hemostats Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on surgical hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for surgical hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The surgical hemostats market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Surgical Hemostats Market Characteristics

3. Surgical Hemostats Market Trends And Strategies

4. Surgical Hemostats Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Surgical Hemostats Growth Analysis And Strategic Analysis Framework

6. Surgical Hemostats Market Segmentation

7. Surgical Hemostats Market Regional And Country Analysis

8. Asia-Pacific Surgical Hemostats Market

9. China Surgical Hemostats Market

10. India Surgical Hemostats Market

11. Japan Surgical Hemostats Market

12. Australia Surgical Hemostats Market

13. Indonesia Surgical Hemostats Market

14. South Korea Surgical Hemostats Market

15. Western Europe Surgical Hemostats Market

16. UK Surgical Hemostats Market

17. Germany Surgical Hemostats Market

18. France Surgical Hemostats Market

19. Italy Surgical Hemostats Market

20. Spain Surgical Hemostats Market

21. Eastern Europe Surgical Hemostats Market

22. Russia Surgical Hemostats Market

23. North America Surgical Hemostats Market

24. USA Surgical Hemostats Market

25. Canada Surgical Hemostats Market

26. South America Surgical Hemostats Market

27. Brazil Surgical Hemostats Market

28. Middle East Surgical Hemostats Market

29. Africa Surgical Hemostats Market

30. Surgical Hemostats Market Competitive Landscape And Company Profiles

31. Surgical Hemostats Market Other Major And Innovative Companies

32. Global Surgical Hemostats Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Surgical Hemostats Market

34. Recent Developments In The Surgical Hemostats Market

35. Surgical Hemostats Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기